{"ticker": {"uuid": "c0abaf88-567c-4f00-931c-7cbd876859d9", "symbol": "DCOY", "name": "Decoy Therapeutics Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Decoy Therapeutics (DCOY) price target increased by 1,100.00% to 30.60", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNVTQ4Sm5HUHpsRHRTakZQLUhJaTlQYmhoYklsUXAtRFVNVk1zNnBnbWozeXVzeGxfeS1EcUlZRkxwZXRLd19menlyV2lLZVlNS28tdVhpU3lka3RjN2w1OE1hbktqV1BlRFhzSy03ZzlMSEJxNmNSRW1LRXIzMEdiSl93TF8wbXhHbDNIQmJHalB6YktxRzNFYUtndG1LN3FZSXZRMkZEYUFYTU84ZFluS2xXYUVHaXNuU2V2Yk53?oc=5", "source_name": "MSN", "published_at": "2026-07-21T06:00:44+00:00", "published_display": "21 Jul 2026 06:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$5.86 | Decoy Therapeutics Inc. Common Stock (DCOY) Stock Price Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1iU2pOQTR0VEVUN2p5OVRrYUh5ZkVSMHctVWJ4TjdaQmZxNU5Udnc0b3pFaWZWU1phM3JVbjNhamQ3TDRvT0Z2YzE0Z0NJQ0RlR3A2dy14MA?oc=5", "source_name": "Binance", "published_at": "2026-07-18T20:20:23+00:00", "published_display": "18 Jul 2026 20:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Decoy Therapeutics (Nasdaq: DCOY) details 2026 annual meeting votes", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxONG9vdlJOSHlac3ptWHhzV09qdUdub3FnV2c2YmFEZk0wQlZhcWRkVWZIdWU0X1BVc3FFQTFpLU43OWJ1Y2QwWlRNU1JVVEN0WGRqZHJQdGNKS3dQM0o3T1dXV0tHTEVNWDhlWUlZQi00ZXpucEd0QUhSdloxN2QyOWJ3eHpxV3NPSFJiNHdMcEZRMFB0Z2x6cHVlLXhackQxajJTYThNclM1c1paUG56aA?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T21:14:50+00:00", "published_display": "15 Jul 2026 21:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Inc. Elects Patricia Gauthier as Class II Director", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOZFJsMjdMcm9paTNmWV9BOGpqdW4zd1IxaEZ6RDVFS2lsY0QwSmJOTFdzM0FTNjB6M0liMDhWaHB4NXdlRktVWTdDaXJxYlEyNW1QRnY4MVNyalhjb0ZXTGpvTTlibm1VOW9nMzBfZDZZdl9Udi1ZTVh0X2N3dnRQYTRuTExDbjFQamtwN1RWYnVMQ1hwRUhtOElHV2JVU0FQZDhHMHB1SmpvUUdma0lOXzdibFBvUElyRGlwTVlR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-15T17:35:46+00:00", "published_display": "15 Jul 2026 17:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics elects Patricia Gauthier to board", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOS3cxZGZxM3hzNERxYWZmNUNIRDFLQW1USEM0WGxrTkFoXzgza3Y4cERqUjFDNTFtZkI3TkJpdkYxTFV4VE51TG0wa3FfeEFZakFZYUkxOFVMa011WjZyMjhwakY1R0JSb2FOM2NSZ2VBc0hMaXBBM2YxRjNqaTFPeGI4elBuSi1tZGptTzctUFJGdjRvWnZtSmRMU0ZDUUpfZjFSazItTFhPZk1ZMmc?oc=5", "source_name": "Investing.com", "published_at": "2026-07-15T14:05:31+00:00", "published_display": "15 Jul 2026 14:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Appoints New Board Member", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxON1NNZlNBdWI0ZDFTcHVFcEZxTTRpR3BnYm9vZXFSd3VzMWxsWVcydmhiZzE1ZXl2WFZlem1TaTNBbnYtbHpSMU5sVGo5NjJMdk9zYWtFT3lvLXBJaERtUnptRFFaU0dxS1RiOTBmT0JXNUdHSkJHMXktUGRoa3QzbUY4NUk?oc=5", "source_name": "Intellectia AI", "published_at": "2026-07-15T13:59:51+00:00", "published_display": "15 Jul 2026 13:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/decoy-therapeutics-stockholders-elect-patricia-132400766.html", "source_name": "PR Newswire", "published_at": "2026-07-15T13:24:00+00:00", "published_display": "15 Jul 2026 13:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Inc. (NASDAQ: DCOY) Share Price, DCOY Stock News, DCOY Share Price & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTFA3eDNfOFFKdTFCb3dWZm9qNEJLTmdaSFBjOFVTTmNtUmZfQTJBS2RON2xvSU93UXVWamRPeFMxcF9fWTJSQk9zMTY5QTM3ZWd4TnQyc2R3?oc=5", "source_name": "Kalkine", "published_at": "2026-07-14T20:00:00+00:00", "published_display": "14 Jul 2026 20:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Company Profile & Introduction", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgJBVV95cUxNNWFwMlNoek1FTE5IekpPNjYyY3FHZzZhaW4zcTQ2QTAwY3U4QkRpdkFOU1ZqUUJqMVJHZ0dmZkRoX3lNMkt4OE9jT3JCRmhUOG5JbWNPTDdhWFlRZ2VmWnBrZkk1UW9OREJ3SlYtQl9lOEVUTDI2YkV4WERaT3dQQkEzQjdMeW9SZFByeGZVc3M3YUkyM3RuNVVJMG9vdDF4RTA0Z3lvdDZxWndSNGFROVB2QXgtaGdGcTZDeFBrdFRudWR2QlFsSEpGWXZTMjRVY3BUaWtRQjV0QW9wa1NSejZ1Tl82eEN4M1pDRkFRZGIxMHJqcURnWGJrRW5YbnB1U1ZBczlfd05VNlZKTEVMWUtIZGxuZmhRWFIydW16MEFVR0lWUTRJVl83aE95bkxJUl9FMWtlR2hqZlF6OHc?oc=5", "source_name": "Moomoo", "published_at": "2026-07-13T14:40:18+00:00", "published_display": "13 Jul 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Decoy Therapeutics (DCOY) Stock Forum and Discussion", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwJBVV95cUxQajJUQTFLSEdDam9TZFBYYzFETlhHc3kxZ0tHS2dlbkktcDlHZWhoaEQzUHpGSHdRc0FvbkQwOWR5VExpdFlZclFwWkVpaEF1VjFBSEtRRkktYU50cTZaM0VNNnlKMDBiQXd3cUs3WlNsZThEazdBSHJSZUQyckxKNEEycmpFYmdQdWhmSHFxbVdyb3Z5SUpidkFIUjZIaG1KUkVZOGl4LVlZQmI1bFdkankzU2t6TFRpMExQSm9faVZPSE5tdWdsejhKSFpBdmd0MVFveDJHR1dXSkpNdnJMQ2J3VVdWRDN6TmZRV3l4YU9GX2tfamVlR3R2RVVYdjdxb1MzLU1iNm1nX21FMXVYazZybTR2YmJqdG81RlRDSlg5U1hBaUVv?oc=5", "source_name": "Moomoo", "published_at": "2026-07-11T20:50:29+00:00", "published_display": "11 Jul 2026 20:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Files to Register Up to 3.77 Million Shares for Resale", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPWVBCejg3cHJUd2ZuMDB6Umgyc0t4eXFzTGl2UXpUNDR1azBuemN6LVI4OFhkSmRjY1dIZUJYallwSVlUdUtxUWtpb3hod01CdmhWY2J4UVBLNl8tVTYybmhhbmxkZV9MQ2dTUXhlMVRZUV9VUUNIT3dMZjRpUzBwMFpxemlhQUNuRklRS0RHVXpfSVMzQnhjY3RYV2tsQjRUbV9aZF9PM1ZxSlRjd0dLZE5hUUgtLWhUai1fTV9yZUlISm04?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-10T20:46:17+00:00", "published_display": "10 Jul 2026 20:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form S-1 Decoy Therapeutics Inc For: 10 July", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPU3JSM3ZXZTB5VGhDZllWVVAtbTBRdU5Vc200Z29KQ1dybEtla0l2eGs0bDlrX2FxNGhCMEhIaTBGcDk3WU15VWpUTTEtdEZicF9FLU5reEg1TDM3bHpkZjZWeHRBeUtvemJpQmRGZ1ZMQnhfTmRacW1idFRFMnpBenkwS2JjcXJDUUY4T3ZnQ0h5Y0hmMUVOT2RtMGdfM2VNV19mZ0pR?oc=5", "source_name": "Investing.com India", "published_at": "2026-07-10T20:39:36+00:00", "published_display": "10 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPUjFHb2M0QkZaMENTMGRpS0d5OGtaRlk1SXZoOVZhOVBvdHV0RnQ4OEpHeFd5NnZyV0ljWEtnSV96UlQ1UUxZWkpoUWxUUzJZb2VXb2FDZHFrMkQxaThTbjZmQkY3WHZ0eGkyb2h5SWpLQ2JzTkZBZEJtM0w2dnJFMVdyWFpSWWtHSUtCb2w2Z1NVSllVWVIwNlV2N0F0d0RVcThWN2dlYjh5aG9fSVZKVV94SW1Oa1pFckhESUQ2bXBUcHBRTF9GZVJORWpLQQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/decoy-therapeutics-ceo-participate-hvivo-120000011.html", "source_name": "PR Newswire", "published_at": "2026-06-08T12:00:00+00:00", "published_display": "08 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/decoy-therapeutics-nominates-global-biopharma-120000188.html", "source_name": "PR Newswire", "published_at": "2026-06-03T12:00:00+00:00", "published_display": "03 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV\u2122 Candidate into the Clinic", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/decoy-therapeutics-partners-hvivo-advance-110000709.html", "source_name": "PR Newswire", "published_at": "2026-06-01T11:00:00+00:00", "published_display": "01 Jun 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Decoy Therapeutics to implement 1-for-12 reverse stock split By Investing.com", "summary": "Decoy Therapeutics Inc. announced a 1-for-12 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement. The split, effective Friday, will reduce outstanding shares and adjust options and warrants without altering ownership percentages. This move follows", "url": "https://za.investing.com/news/company-news/decoy-therapeutics-to-implement-1for12-reverse-stock-split-93CH-4149275", "source_name": "Investing.com South Africa", "published_at": "2026-03-10T15:08:32", "published_display": "10 Mar 2026 15:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Announces 1-for-12 Reverse Stock Split", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPVThYQkxuMmdrVnRzYzBIN3dPMUtmVkRmZFA4U2V5UENXSFhlNEs0akFTVGhrWE5aZGx2OUhlTm5ROU5XeE9DSVpZb0tPVzBOU2xKOVBfWk1fcUhxYWUwSlRkM3UtLWVwdDZZYUR1NTNlNTdBY2dmS3piMVJzTnhhaG4zdUJ6aGN4T1VlbFpidGx3TTBoaTJYN24zU0FESW1ZM0Q2Q1NrRkdGakVkUmRUWlZjYw?oc=5", "source_name": "PR Newswire", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics (DCOY) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE9aem9EdlpBR3lYMGwyWE40NDk5VDg3LTA2Z2pMa1d1WG1OaVk1VHh5UG1sQ3VKaUlhME9rQ2NEaUJNN0pYWW1peE53Tm9LMXdMMnN4NVVQWWE1UQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-01-23T17:39:06+00:00", "published_display": "23 Jan 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics (DCOY) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE93d0hka3VGOGh5WkVzTnBjaXVMVV9rTlBhMks0WFJLWTlkbS1RWEQ2UUNzVEFTOWMxeEN4azFwVC0wLTZpT3hqZVZWNGVKNi1HN0JDc1lzOEp1d2I2aW5KdjVhdkU5UQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics(DCOY) Stock Options Chain | Quotes & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE45aTB3b0RwMm1weGhJSEZNNjVBNWU3QWtpeURGUEpXN0JnV3BOSU9hc0l1aFpRMDBGellCNUNlUldVVEZ2M2o5LWxzZXk1TjBVTFVTeF96ZFl4WXpNNFJN?oc=5", "source_name": "Moomoo", "published_at": "2026-01-13T14:01:03+00:00", "published_display": "13 Jan 2026 14:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DCOY Stock Price and Chart \u2014 NASDAQ:DCOY", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE5EcnpCaTQzWnVkV2dPQjIwVTR2X1lDcDhZSXR6dHFXTF94VGttYlU4NnFBbWxHQThpNC1laldJR3EwbnB4eVIxdEp0emxEZ3NBU2M5RzBzMUxyQk1f?oc=5", "source_name": "TradingView", "published_at": "2026-01-08T15:45:02+00:00", "published_display": "08 Jan 2026 15:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOcFpNUW1odEhjWXhkSkVtZk5EeTBweDhBbUtHdDk4VzZqVTVHTWVTWUJiNmVIY3ZXSGtNb1gyZzRvaFBVZ05kZEc1cVpFdDZ4UVluYXVfYTFVNnN5cUNXV0hKVXVITWJ0S0ZscFFjWVdIbHRqeVdKYnJMM0JjUXp6dU5PdFR2TUE2cmV6R0ZsSXJEa052RzRYOQ?oc=5", "source_name": "Market source", "published_at": "2026-01-07T08:00:00+00:00", "published_display": "07 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Decoy Therapeutics (DCOY) price target increased by 1,100.00% to 30.60", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNVTQ4Sm5HUHpsRHRTakZQLUhJaTlQYmhoYklsUXAtRFVNVk1zNnBnbWozeXVzeGxfeS1EcUlZRkxwZXRLd19menlyV2lLZVlNS28tdVhpU3lka3RjN2w1OE1hbktqV1BlRFhzSy03ZzlMSEJxNmNSRW1LRXIzMEdiSl93TF8wbXhHbDNIQmJHalB6YktxRzNFYUtndG1LN3FZSXZRMkZEYUFYTU84ZFluS2xXYUVHaXNuU2V2Yk53?oc=5", "source_name": "MSN", "published_at": "2026-07-21T06:00:44+00:00", "published_display": "21 Jul 2026 06:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$5.86 | Decoy Therapeutics Inc. Common Stock (DCOY) Stock Price Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1iU2pOQTR0VEVUN2p5OVRrYUh5ZkVSMHctVWJ4TjdaQmZxNU5Udnc0b3pFaWZWU1phM3JVbjNhamQ3TDRvT0Z2YzE0Z0NJQ0RlR3A2dy14MA?oc=5", "source_name": "Binance", "published_at": "2026-07-18T20:20:23+00:00", "published_display": "18 Jul 2026 20:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics (Nasdaq: DCOY) details 2026 annual meeting votes", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxONG9vdlJOSHlac3ptWHhzV09qdUdub3FnV2c2YmFEZk0wQlZhcWRkVWZIdWU0X1BVc3FFQTFpLU43OWJ1Y2QwWlRNU1JVVEN0WGRqZHJQdGNKS3dQM0o3T1dXV0tHTEVNWDhlWUlZQi00ZXpucEd0QUhSdloxN2QyOWJ3eHpxV3NPSFJiNHdMcEZRMFB0Z2x6cHVlLXhackQxajJTYThNclM1c1paUG56aA?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T21:14:50+00:00", "published_display": "15 Jul 2026 21:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Inc. Elects Patricia Gauthier as Class II Director", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOZFJsMjdMcm9paTNmWV9BOGpqdW4zd1IxaEZ6RDVFS2lsY0QwSmJOTFdzM0FTNjB6M0liMDhWaHB4NXdlRktVWTdDaXJxYlEyNW1QRnY4MVNyalhjb0ZXTGpvTTlibm1VOW9nMzBfZDZZdl9Udi1ZTVh0X2N3dnRQYTRuTExDbjFQamtwN1RWYnVMQ1hwRUhtOElHV2JVU0FQZDhHMHB1SmpvUUdma0lOXzdibFBvUElyRGlwTVlR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-15T17:35:46+00:00", "published_display": "15 Jul 2026 17:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics elects Patricia Gauthier to board", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOS3cxZGZxM3hzNERxYWZmNUNIRDFLQW1USEM0WGxrTkFoXzgza3Y4cERqUjFDNTFtZkI3TkJpdkYxTFV4VE51TG0wa3FfeEFZakFZYUkxOFVMa011WjZyMjhwakY1R0JSb2FOM2NSZ2VBc0hMaXBBM2YxRjNqaTFPeGI4elBuSi1tZGptTzctUFJGdjRvWnZtSmRMU0ZDUUpfZjFSazItTFhPZk1ZMmc?oc=5", "source_name": "Investing.com", "published_at": "2026-07-15T14:05:31+00:00", "published_display": "15 Jul 2026 14:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Appoints New Board Member", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxON1NNZlNBdWI0ZDFTcHVFcEZxTTRpR3BnYm9vZXFSd3VzMWxsWVcydmhiZzE1ZXl2WFZlem1TaTNBbnYtbHpSMU5sVGo5NjJMdk9zYWtFT3lvLXBJaERtUnptRFFaU0dxS1RiOTBmT0JXNUdHSkJHMXktUGRoa3QzbUY4NUk?oc=5", "source_name": "Intellectia AI", "published_at": "2026-07-15T13:59:51+00:00", "published_display": "15 Jul 2026 13:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/decoy-therapeutics-stockholders-elect-patricia-132400766.html", "source_name": "PR Newswire", "published_at": "2026-07-15T13:24:00+00:00", "published_display": "15 Jul 2026 13:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Inc. (NASDAQ: DCOY) Share Price, DCOY Stock News, DCOY Share Price & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTFA3eDNfOFFKdTFCb3dWZm9qNEJLTmdaSFBjOFVTTmNtUmZfQTJBS2RON2xvSU93UXVWamRPeFMxcF9fWTJSQk9zMTY5QTM3ZWd4TnQyc2R3?oc=5", "source_name": "Kalkine", "published_at": "2026-07-14T20:00:00+00:00", "published_display": "14 Jul 2026 20:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Company Profile & Introduction", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgJBVV95cUxNNWFwMlNoek1FTE5IekpPNjYyY3FHZzZhaW4zcTQ2QTAwY3U4QkRpdkFOU1ZqUUJqMVJHZ0dmZkRoX3lNMkt4OE9jT3JCRmhUOG5JbWNPTDdhWFlRZ2VmWnBrZkk1UW9OREJ3SlYtQl9lOEVUTDI2YkV4WERaT3dQQkEzQjdMeW9SZFByeGZVc3M3YUkyM3RuNVVJMG9vdDF4RTA0Z3lvdDZxWndSNGFROVB2QXgtaGdGcTZDeFBrdFRudWR2QlFsSEpGWXZTMjRVY3BUaWtRQjV0QW9wa1NSejZ1Tl82eEN4M1pDRkFRZGIxMHJqcURnWGJrRW5YbnB1U1ZBczlfd05VNlZKTEVMWUtIZGxuZmhRWFIydW16MEFVR0lWUTRJVl83aE95bkxJUl9FMWtlR2hqZlF6OHc?oc=5", "source_name": "Moomoo", "published_at": "2026-07-13T14:40:18+00:00", "published_display": "13 Jul 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics (DCOY) Stock Forum and Discussion", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwJBVV95cUxQajJUQTFLSEdDam9TZFBYYzFETlhHc3kxZ0tHS2dlbkktcDlHZWhoaEQzUHpGSHdRc0FvbkQwOWR5VExpdFlZclFwWkVpaEF1VjFBSEtRRkktYU50cTZaM0VNNnlKMDBiQXd3cUs3WlNsZThEazdBSHJSZUQyckxKNEEycmpFYmdQdWhmSHFxbVdyb3Z5SUpidkFIUjZIaG1KUkVZOGl4LVlZQmI1bFdkankzU2t6TFRpMExQSm9faVZPSE5tdWdsejhKSFpBdmd0MVFveDJHR1dXSkpNdnJMQ2J3VVdWRDN6TmZRV3l4YU9GX2tfamVlR3R2RVVYdjdxb1MzLU1iNm1nX21FMXVYazZybTR2YmJqdG81RlRDSlg5U1hBaUVv?oc=5", "source_name": "Moomoo", "published_at": "2026-07-11T20:50:29+00:00", "published_display": "11 Jul 2026 20:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Files to Register Up to 3.77 Million Shares for Resale", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPWVBCejg3cHJUd2ZuMDB6Umgyc0t4eXFzTGl2UXpUNDR1azBuemN6LVI4OFhkSmRjY1dIZUJYallwSVlUdUtxUWtpb3hod01CdmhWY2J4UVBLNl8tVTYybmhhbmxkZV9MQ2dTUXhlMVRZUV9VUUNIT3dMZjRpUzBwMFpxemlhQUNuRklRS0RHVXpfSVMzQnhjY3RYV2tsQjRUbV9aZF9PM1ZxSlRjd0dLZE5hUUgtLWhUai1fTV9yZUlISm04?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-10T20:46:17+00:00", "published_display": "10 Jul 2026 20:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form S-1 Decoy Therapeutics Inc For: 10 July", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPU3JSM3ZXZTB5VGhDZllWVVAtbTBRdU5Vc200Z29KQ1dybEtla0l2eGs0bDlrX2FxNGhCMEhIaTBGcDk3WU15VWpUTTEtdEZicF9FLU5reEg1TDM3bHpkZjZWeHRBeUtvemJpQmRGZ1ZMQnhfTmRacW1idFRFMnpBenkwS2JjcXJDUUY4T3ZnQ0h5Y0hmMUVOT2RtMGdfM2VNV19mZ0pR?oc=5", "source_name": "Investing.com India", "published_at": "2026-07-10T20:39:36+00:00", "published_display": "10 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPUjFHb2M0QkZaMENTMGRpS0d5OGtaRlk1SXZoOVZhOVBvdHV0RnQ4OEpHeFd5NnZyV0ljWEtnSV96UlQ1UUxZWkpoUWxUUzJZb2VXb2FDZHFrMkQxaThTbjZmQkY3WHZ0eGkyb2h5SWpLQ2JzTkZBZEJtM0w2dnJFMVdyWFpSWWtHSUtCb2w2Z1NVSllVWVIwNlV2N0F0d0RVcThWN2dlYjh5aG9fSVZKVV94SW1Oa1pFckhESUQ2bXBUcHBRTF9GZVJORWpLQQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/decoy-therapeutics-ceo-participate-hvivo-120000011.html", "source_name": "PR Newswire", "published_at": "2026-06-08T12:00:00+00:00", "published_display": "08 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/decoy-therapeutics-nominates-global-biopharma-120000188.html", "source_name": "PR Newswire", "published_at": "2026-06-03T12:00:00+00:00", "published_display": "03 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV\u2122 Candidate into the Clinic", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/decoy-therapeutics-partners-hvivo-advance-110000709.html", "source_name": "PR Newswire", "published_at": "2026-06-01T11:00:00+00:00", "published_display": "01 Jun 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics to implement 1-for-12 reverse stock split By Investing.com", "summary": "Decoy Therapeutics Inc. announced a 1-for-12 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement. The split, effective Friday, will reduce outstanding shares and adjust options and warrants without altering ownership percentages. This move follows", "url": "https://za.investing.com/news/company-news/decoy-therapeutics-to-implement-1for12-reverse-stock-split-93CH-4149275", "source_name": "Investing.com South Africa", "published_at": "2026-03-10T15:08:32", "published_display": "10 Mar 2026 15:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics Announces 1-for-12 Reverse Stock Split", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPVThYQkxuMmdrVnRzYzBIN3dPMUtmVkRmZFA4U2V5UENXSFhlNEs0akFTVGhrWE5aZGx2OUhlTm5ROU5XeE9DSVpZb0tPVzBOU2xKOVBfWk1fcUhxYWUwSlRkM3UtLWVwdDZZYUR1NTNlNTdBY2dmS3piMVJzTnhhaG4zdUJ6aGN4T1VlbFpidGx3TTBoaTJYN24zU0FESW1ZM0Q2Q1NrRkdGakVkUmRUWlZjYw?oc=5", "source_name": "PR Newswire", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics (DCOY) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE9aem9EdlpBR3lYMGwyWE40NDk5VDg3LTA2Z2pMa1d1WG1OaVk1VHh5UG1sQ3VKaUlhME9rQ2NEaUJNN0pYWW1peE53Tm9LMXdMMnN4NVVQWWE1UQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-01-23T17:39:06+00:00", "published_display": "23 Jan 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics (DCOY) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE93d0hka3VGOGh5WkVzTnBjaXVMVV9rTlBhMks0WFJLWTlkbS1RWEQ2UUNzVEFTOWMxeEN4azFwVC0wLTZpT3hqZVZWNGVKNi1HN0JDc1lzOEp1d2I2aW5KdjVhdkU5UQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Decoy Therapeutics(DCOY) Stock Options Chain | Quotes & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE45aTB3b0RwMm1weGhJSEZNNjVBNWU3QWtpeURGUEpXN0JnV3BOSU9hc0l1aFpRMDBGellCNUNlUldVVEZ2M2o5LWxzZXk1TjBVTFVTeF96ZFl4WXpNNFJN?oc=5", "source_name": "Moomoo", "published_at": "2026-01-13T14:01:03+00:00", "published_display": "13 Jan 2026 14:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DCOY Stock Price and Chart \u2014 NASDAQ:DCOY", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE5EcnpCaTQzWnVkV2dPQjIwVTR2X1lDcDhZSXR6dHFXTF94VGttYlU4NnFBbWxHQThpNC1laldJR3EwbnB4eVIxdEp0emxEZ3NBU2M5RzBzMUxyQk1f?oc=5", "source_name": "TradingView", "published_at": "2026-01-08T15:45:02+00:00", "published_display": "08 Jan 2026 15:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOcFpNUW1odEhjWXhkSkVtZk5EeTBweDhBbUtHdDk4VzZqVTVHTWVTWUJiNmVIY3ZXSGtNb1gyZzRvaFBVZ05kZEc1cVpFdDZ4UVluYXVfYTFVNnN5cUNXV0hKVXVITWJ0S0ZscFFjWVdIbHRqeVdKYnJMM0JjUXp6dU5PdFR2TUE2cmV6R0ZsSXJEa052RzRYOQ?oc=5", "source_name": "Market source", "published_at": "2026-01-07T08:00:00+00:00", "published_display": "07 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 69, "total_relevant": 32, "sentiment_summary": {"positive": 1, "negative": 1, "neutral": 30, "score": 50, "total": 32, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 11.55, "count": 21}, {"event": "earnings", "label": "Earnings", "weight": 3.71, "count": 9}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 5.61, "latest_week": "2026-07-17", "one_week_move": -5.1, "four_week_move": -7.6, "twelve_week_move": 3.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -22.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 40.0541, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.1% over one week, -7.6% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 7}, {"label": "PR Newswire", "count": 6}, {"label": "Moomoo", "count": 3}, {"label": "marketscreener.com", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "MarketBeat", "count": 2}, {"label": "MSN", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 23}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 21}, {"label": "Earnings", "count": 9}, {"label": "Analyst action", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "23", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-5.1% over one week, -7.6% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Decoy Therapeutics (DCOY) price target increased by 1,100.00% to 30.60"}], "updated_at": "2026-07-23T06:51:15.839131+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}